SCHEMBL15467375

SCHEMBL15467375

CN1CC(=O)N(CCCCN)C1=O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLA2G7 Q13093 1/20 0.45
HDAC6 Q9UBN7 1/20 0.38
RECQL P46063 3/20 0.37
ALDH1A1 P00352 3/20 0.37
HEXA P06865 2/20 0.37
HEXB P07686 2/20 0.37
NR1H2 P55055 2/20 0.34
NR1H3 Q13133 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
MAPT P10636 2/20 0.33
KDM4E B2RXH2 1/20 0.33
USP2 O75604 1/20 0.33
POLB P06746 1/20 0.33
BLM P54132 1/20 0.33
PDE5A O76074 1/20 0.33
GFER P55789 1/20 0.33
PIM1 P11309 1/20 0.33
FAAH O00519 2/20 0.31
MGLL Q99685 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22702280 0.86 PLA2G7 (0.49) PLA2G7HDAC6RECQLALDH1A1HEXA
SCHEMBL13204644 0.82 MGLL (0.47) PLA2G7HDAC6ALDH1A1NR1H2NR1H3
SCHEMBL11252578 0.81 MGLL (0.50) PLA2G7ALDH1A1PDE5AFAAHMGLL
SCHEMBL30372493 0.81 MGLL (0.50) PLA2G7ALDH1A1PDE5AFAAHMGLL
SCHEMBL11264830 0.81 MGLL (0.50) PLA2G7ALDH1A1PDE5AFAAHMGLL
SCHEMBL17213445 0.80 PLA2G7 (0.47) PLA2G7HDAC6RECQLALDH1A1NR1H2
SCHEMBL9190811 0.78 PLA2G7 (0.46) PLA2G7HDAC6RECQLALDH1A1NR1H2
SCHEMBL13204456 0.77 HRH3 (0.47) PLA2G7HDAC6ALDH1A1HRH1GAA
SCHEMBL13204370 0.77 KCNH2 (0.43) PLA2G7ALDH1A1USP2HTR1ADRD2
SCHEMBL21927803 0.76 PLA2G7 (0.44) PLA2G7HDAC6RECQLALDH1A1NR1H2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2678349-B1 C-4\" POSITION SUBSTITUTED MACROLIDE DERIVATIVE TAISHO PHARMACEUTICAL CO LTD (JP) 2016-01-13 EP disclosed
US-9139609-B2 C-4″ position substituted macrolide derivative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2015-09-22 US disclosed
US-20140046043-A1 C-4\" POSITION SUBSTITUTED MACROLIDE DERIVATIVE MEIJI SEIKA PHARMA CO., LTD. (JP) 2014-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140046043-A1 C-4\" POSITION SUBSTITUTED MACROLIDE DERIVATIVE MRPL21, MRPS34, MRPL37 PLA2G7 4284/4885HDAC6 783/4885RECQL 1459/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.